IP Verse

Novel Polymorphic Forms Of Perindopril (L)-Arginine And Process For The Preparation Thereof

Patent No. EP2318365 (titled "Novel Polymorphic Forms Of Perindopril (L)-Arginine And Process For The Preparation Thereof") was filed by Matrix Laboratories on Jun 22, 2009. The application was issued on Aug 12, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LES LABORATOIRES SERVIERMay 12, 2016CASALONGA
ACTAVIS GROUP PTC EHFMay 11, 2016D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2318365

MATRIX LABORATORIES
Application Number
EP09769810A
Filing Date
Jun 22, 2009
Status
Revoked
Jul 6, 2018
Publication Date
Aug 12, 2015
External Links
Slate, Register , Google Patents